LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.95 | 770.25 | 4152 | 4543 | 0.9138 | 0.9308 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.95 | 770.25 | 4584 | 4543 | 1.0088 | 1.0069 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.17 | 770.25 | 4495 | 5010 | 0.8971 | 0.9212 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.17 | 770.25 | 4933 | 5010 | 0.9845 | 0.9885 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.39 | 770.25 | 4836 | 5404 | 0.8948 | 0.9225 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.39 | 770.25 | 5343 | 5404 | 0.9886 | 0.9919 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.61 | 770.25 | 5225 | 5813 | 0.8989 | 0.9282 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.61 | 770.25 | 5717 | 5813 | 0.9835 | 0.9886 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.83 | 770.25 | 5552 | 6223 | 0.8921 | 0.9257 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.83 | 770.25 | 6261 | 6223 | 1.0060 | 1.0040 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.05 | 770.25 | 5926 | 6629 | 0.8939 | 0.9290 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.05 | 770.25 | 6630 | 6629 | 1.0001 | 1.0000 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.27 | 770.25 | 6226 | 7058 | 0.8820 | 0.9230 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.27 | 770.25 | 7041 | 7058 | 0.9975 | 0.9984 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.49 | 770.25 | 6449 | 7555 | 0.8536 | 0.9061 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.49 | 770.25 | 7349 | 7555 | 0.9727 | 0.9833 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.71 | 770.25 | 6829 | 8001 | 0.8535 | 0.9083 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.71 | 770.25 | 7760 | 8001 | 0.9698 | 0.9819 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.94 | 770.25 | 7041 | 8444 | 0.8338 | 0.8975 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.94 | 770.25 | 8096 | 8444 | 0.9587 | 0.9758 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.16 | 770.25 | 7316 | 8892 | 0.8228 | 0.8924 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.16 | 770.25 | 8463 | 8892 | 0.9518 | 0.9722 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.39 | 770.25 | 7476 | 9326 | 0.8016 | 0.8808 | MN20160304_L02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.39 | 770.25 | 8815 | 9326 | 0.9452 | 0.9689 | MN20160304_L02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 65.61 | 770.25 | 7752 | 9736 | 0.7962 | 0.8793 | MN20160304_L02 | E06 |